Favezelimab (Anti-LAG3 / CD223)

Favezelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody that targets LAG-3. It has the potential for colorectal cancer (CRC) research. MW :145.98 KD.

• Supplier: Selleck Chemicals
• Product #: A2994
• Sku #: A2994-1mg*25